lovastatin has been researched along with Respiratory Syncytial Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Ravi, LI; Sugrue, RJ; Sutejo, R; Tan, BH; Wong, PS | 1 |
| Gower, TL; Graham, BS | 1 |
2 other study(ies) available for lovastatin and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Lovastatin treatment mitigates the pro-inflammatory cytokine response in respiratory syncytial virus infected macrophage cells.
Topics: Animals; Antiviral Agents; Cytokines; Female; Humans; Lovastatin; Macrophages; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2013 |
Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro.
Topics: Acute Disease; Animals; Antiviral Agents; Cell Fusion; Cell Line; Cholesterol; Female; Lovastatin; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Respiratory Syncytial Virus Infections; Virus Replication | 2001 |